These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 1384524)
21. Hepatitis C infection and viremia in Dutch hemophilia patients. Mauser-Bunschoten EP; Bresters D; van Drimmelen AA; Roosendaal G; Cuypers HT; Reesink HW; van der Poel CL; van den Berg HM; Lelie PN J Med Virol; 1995 Mar; 45(3):241-6. PubMed ID: 7539831 [TBL] [Abstract][Full Text] [Related]
22. Transmission of HCV infection by RIBA indeterminate and positive blood units. Kolho E; Naukkarinen R; Krusius T Transfus Med; 1992 Sep; 2(3):243-8. PubMed ID: 1285012 [TBL] [Abstract][Full Text] [Related]
23. Non-A, non-B hepatitis and the anti-HCV assay. Barbara JA; Contreras M Vox Sang; 1991; 60(1):1-7. PubMed ID: 1711260 [TBL] [Abstract][Full Text] [Related]
24. Seroconversion to hepatitis C virus antibodies in patients with acute posttransfusion non-A, non-B hepatitis in Sweden with a second generation test. Mattsson L; Grillner L; Weiland O Scand J Infect Dis; 1992; 24(1):15-20. PubMed ID: 1375390 [TBL] [Abstract][Full Text] [Related]
25. Patterns of serological markers in transfusion-transmitted hepatitis C virus infection using second-generation HCV assays. Lelie PN; Cuypers HT; Reesink HW; van der Poel CL; Winkel I; Bakker E; van Exel-Oehlers PJ; Vallari D; Allain JP; Mimms L J Med Virol; 1992 Jul; 37(3):203-9. PubMed ID: 1331309 [TBL] [Abstract][Full Text] [Related]
26. Prevalence of hepatitis C virus infection among long-term hemodialysis patients: detection of hepatitis C virus RNA in plasma. Sakamoto N; Enomoto N; Marumo F; Sato C J Med Virol; 1993 Jan; 39(1):11-5. PubMed ID: 7678636 [TBL] [Abstract][Full Text] [Related]
27. Testing for HCV markers. Reesink HW; van der Poel CL; Bresters D; Cuypers HT; Zaaijer H; Lelie PN Dev Biol Stand; 1993; 81():77-84. PubMed ID: 7513661 [TBL] [Abstract][Full Text] [Related]
28. Hepatitis C virus antibodies among risk groups in a South African area endemic for hepatitis B virus. Soni PN; Tait DR; Kenoyer DG; Fernandes-Costa F; Naicker S; Gopaul W; Simjee AE J Med Virol; 1993 May; 40(1):65-8. PubMed ID: 7685810 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of third-generation screening and confirmatory assays for HCV antibodies. Uyttendaele S; Claeys H; Mertens W; Verhaert H; Vermylen C Vox Sang; 1994; 66(2):122-9. PubMed ID: 7514324 [TBL] [Abstract][Full Text] [Related]
30. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Barrera JM; Francis B; Ercilla G; Nelles M; Achord D; Darner J; Lee SR Vox Sang; 1995; 68(1):15-8. PubMed ID: 7536987 [TBL] [Abstract][Full Text] [Related]
31. Hepatitis C infection in BMT patients. Kolho E; Ruutu P; Ruutu T Bone Marrow Transplant; 1993 Feb; 11(2):119-23. PubMed ID: 7679597 [TBL] [Abstract][Full Text] [Related]
32. Expression of Hepatitis C Virus Core and E2 antigenic recombinant proteins and their use for development of diagnostic assays. Ali A; Nisar M; Idrees M; Rafique S; Iqbal M Int J Infect Dis; 2015 May; 34():84-9. PubMed ID: 25796431 [TBL] [Abstract][Full Text] [Related]
33. Clinical significance of antibodies to nonstructural and core proteins of hepatitis C virus in posttransfusion hepatitis patients during long-term follow-up. Tanaka E; Kiyosawa K; Nakatsuji Y; Inoue Y; Miyamura T; Chiba J; Furuta S J Med Virol; 1993 Apr; 39(4):318-24. PubMed ID: 7684063 [TBL] [Abstract][Full Text] [Related]
34. Hepatitis C core antibody detection in acute hepatitis and cirrhosis patients from Tunisia. Coursaget P; Simpson B; el Goulli N; Ben Khelifa H; Kastally R Pathol Biol (Paris); 1992 Jun; 40(6):646-8. PubMed ID: 1383914 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia, Northeastern Brazil: analysis of serological and virological parameters. Silva LK; Silva MB; Lopes GB; Rodart IF; Costa FQ; Santana NP; Paraná R; Santana A; Reis MG Rev Soc Bras Med Trop; 2005; 38(6):496-502. PubMed ID: 16410926 [TBL] [Abstract][Full Text] [Related]
36. Transmission of hepatitis C virus to sexual partners of seropositive patients with bleeding disorders: a rare event. Kolho E; Naukkarinen R; Ebeling F; Rasi V; Ikkala E; Krusius T Scand J Infect Dis; 1991; 23(6):667-70. PubMed ID: 1667715 [TBL] [Abstract][Full Text] [Related]
37. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland. Davoren A; Dillon AD; Power JP; Donnellan J; Quinn JM; Willis JW; Lawlor EM; O'Riordan JM Transfusion; 2002 Nov; 42(11):1501-6. PubMed ID: 12421225 [TBL] [Abstract][Full Text] [Related]
38. Effect of human immunodeficiency virus infection on hepatitis C virus infection in hemophiliacs. Ghany MG; Leissinger C; Lagier R; Sanchez-Pescador R; Lok AS Dig Dis Sci; 1996 Jun; 41(6):1265-72. PubMed ID: 8654162 [TBL] [Abstract][Full Text] [Related]
39. [Enzyme-linked immunosorbent assay for antibodies against core protein of hepatitis C virus with a synthetic oligopeptide]. Sugiyasu T Fukuoka Igaku Zasshi; 1993 Apr; 84(4):148-58. PubMed ID: 7686127 [TBL] [Abstract][Full Text] [Related]
40. Also with a restrictive transfusion policy, screening with second-generation anti-hepatitis C virus enzyme-linked immunosorbent assay would have reduced post-transfusion hepatitis C after open-heart surgery. Mathiesen UL; Karlsson E; Foberg U; Frydén A; Franzén L; Widell A; Bodemar G Scand J Gastroenterol; 1993 Jul; 28(7):581-4. PubMed ID: 7689744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]